Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| DEPOMED INC | 84,589 | reported | 08 May 2020 | tx 30+329,416−104,449 |
| Vaccitech plc | 20,174 | reported | 10 Jun 2025 | tx 6+113,519 |
| GENAISSANCE PHARMACEUTICALS INC | 10,000 | reported | 30 Sept 2003 | tx 1+10,000 |
| REPLIGEN CORP | 2,239 | reported | 14 May 2026 | tx 169+407,649−268,699 |
| PROTEIN DESIGN LABS INC/DE | 0 | reported | 29 Apr 2008 | tx 20+110,500−250 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 14 May 2026 | GRANT_AWARD | REPLIGEN CORP | 995 | 0.00 USD | |
| 14 May 2026 | GRANT_AWARD | REPLIGEN CORP | 2,239 | 0.00 USD | deriv |
| 17 Dec 2025 | SALE | REPLIGEN CORP | 275 | 161.00 USD | |
| 10 Jun 2025 | GRANT_AWARD | Vaccitech plc | 20,174 | 0.00 USD | deriv |
| 15 May 2025 | GRANT_AWARD | REPLIGEN CORP | 973 | 0.00 USD | |
| 15 May 2025 | GRANT_AWARD | REPLIGEN CORP | 1,800 | 0.00 USD | deriv |
| 14 Jun 2024 | EXERCISE | REPLIGEN CORP | 2,953 | 67.71 USD | |
| 14 Jun 2024 | EXERCISE | REPLIGEN CORP | 2,953 | 0.00 USD | deriv |
| 16 May 2024 | GRANT_AWARD | REPLIGEN CORP | 803 | 0.00 USD | |
| 16 May 2024 | GRANT_AWARD | REPLIGEN CORP | 1,576 | 0.00 USD | deriv |
| 10 May 2024 | GRANT_AWARD | Vaccitech plc | 19,516 | 0.00 USD | deriv |
| 27 Feb 2024 | SALE | REPLIGEN CORP | 1,000 | 193.35 USD | |
| 27 Feb 2024 | EXERCISE | REPLIGEN CORP | 4,626 | 42.07 USD | |
| 27 Feb 2024 | EXERCISE | REPLIGEN CORP | 4,626 | 0.00 USD | deriv |
| 29 Aug 2023 | SALE | REPLIGEN CORP | 850 | 171.38 USD | |
| 29 Aug 2023 | EXERCISE | REPLIGEN CORP | 7,392 | 18.12 USD | |
| 29 Aug 2023 | EXERCISE | REPLIGEN CORP | 7,392 | 0.00 USD | deriv |
| 18 May 2023 | GRANT_AWARD | REPLIGEN CORP | 798 | 0.00 USD | |
| 18 May 2023 | GRANT_AWARD | REPLIGEN CORP | 1,730 | 0.00 USD | deriv |
| 11 May 2023 | GRANT_AWARD | Vaccitech plc | 19,197 | 0.00 USD | deriv |
| 15 Jun 2022 | GRANT_AWARD | Vaccitech plc | 18,604 | 0.00 USD | deriv |
| 09 Sept 2022 | SALE | REPLIGEN CORP | 775 | 227.17 USD | |
| 26 May 2022 | GRANT_AWARD | REPLIGEN CORP | 644 | 0.00 USD | |
| 26 May 2022 | GRANT_AWARD | REPLIGEN CORP | 1,565 | 0.00 USD | deriv |
| 25 May 2022 | SALE | REPLIGEN CORP | 2,576 | 149.18 USD |
4 purchases reported after at least 12 months of silence — most recent on 04 May 2021.